"T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy" by Brian B. Gowen

Article

T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy

PLoS ONE

Brian B. Gowen, Utah State University
Donald F. Smee, Utah State University
Jeffery O. Hall, Utah State University
M. Wong
K. Jung, Utah State University
K. W. Bailey, Utah State University
J. R. Stevens
Y. Furuta
John D. Morrey, Utah State University

Link

Document Type

Article

Publisher

PLoS

Publication Date

1-1-2008

Disciplines

Animal Sciences,
Dairy Science and
Veterinary Medicine

Citation Information

Gowen BB, Smee DF, Hall JO, Wong M, Jung K, Bailey KW, Stevens JR, YF, and Morrey JD. T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model: T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to Ribavirin Therapy. PLoS ONE 3(11):e3725, 2008.